Sergliflozin-A
Sergliflozin-A is a compound used to inhibit type 2 diabetes. It can inhibit glucose transporters in the kidney, competitively inhibit hSGLT1 and hSGLT2, and mutations at different sites have different effects on its inhibitory effect.
Product Specifications
CAS Number
360775-96-8
UNSPSC
12352005
Target
SGLT
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Neuroscience-Neuromodulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/sergliflozin-a.html
Smiles
COC(C=C1)=CC=C1CC(C=CC=C2)=C2O[C@@H]3O[C@@H]([C@H]([C@@H]([C@H]3O)O)O)CO
Molecular Formula
C20H24O7
Molecular Weight
376.40
References & Citations
[1]Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and …
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
SGLT1; SGLT2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RAF-444-1 1 mL
TRITC Conjugated Goat Affinity Purified Antibody to Mouse IgG + IgM (min.x Hu., Bov., Eq.)
Sign In for Pricing
View Details 
TP327007M 100 µg
14-3-3 zeta (YWHAZ) (NM_001135701) Human Recombinant Protein
Sign In for Pricing
View Details 
TA361451 100 µL
Phospholipase C beta 3 (PLCB3) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details 
GA117526 1 Kit
Human Leucine rich repeat containing protein 9 (LRRC9) activation kit by CRISPRa
Sign In for Pricing
View Details 
LC424934 20 µg
Complement C3 (C3) (NM_000064) Human Over-expression Lysate
Sign In for Pricing
View Details 